| Date | Title | Description |
| 09.09.2026 | Encoded Therapeutics Inks $275 Million in Series F |
SOUTH SAN FRANCISCO, CA, Encoded Therapeutics, a clinical-stage biotechnology company, announced the close of a $275 million financing.
>> Click here for more funding data on Encoded Therapeutics
>> To export Encoded Therapeuti... |
| 26.08.2026 | Salim Ramji’s Vanguard strikes $4 billion deal to buy wealth platform Altruist: Report | Vanguard Group has agreed to acquire wealth management technology company Altruist for about $4 billion, expanding the asset manager’s reach into financial advice and the growing market for independent financial advisers, according to Wall ... |
| 21.08.2026 | Devoted Health is raising a new round of funding at a $25 billion valuation | Devoted Health is the latest startup to show that combining health and AI commands a premium valuation.
Just months after announcing a new round of funding, the Medicare Advantage startup is in talks to raise another round that could value ... |
| 13.08.2026 | Aligned Marketplace Raises $20M to Scale Independent Primary Care | What You Should Know
Healthcare marketplace Aligned Marketplace secured $20M in Series A funding led by healthcare venture firm Venrock.
The platform directly connects self-insured employers and Third-Party Administrators (TPAs) to a nation... |
| 10.08.2026 | Expedition Therapeutics Closes $115 Million Series B |
SAN FRANCISCO, CA, Expedition Therapeutics, a clinical-stage biotechnology company developing novel oral small molecule therapies for inflammatory and respiratory diseases, announced the closing of an oversubscribed $115 million Series B f... |
| 09.08.2026 | Expedition Therapeutics Lands $115M Series B |
SAN FRANCISCO, CA, Expedition Therapeutics has announced the closing of an oversubscribed $115 million Series B financing round.
>> Click here for more funding data on Expedition Therapeutics
>> To export Expedition Therapeutic... |
| 05.08.2026 | Expedition Therapeutics Raises $115M in Series B Funding | Expedition Therapeutics, a San Francisco, CA-based clinical-stage biotechnology platform, raised $115M in Series B financing.
The round was led by General Atlantic with participation from RA Capital, Vivo Capital, Sofinnova Investments, Nov... |
| 08.07.2026 | Arca Emerges With $64M Seed and Series A |
NEW YORK, NY, Arca, an AI-native wealth management company that brings personalized, advisor-led financial services, has exited stealth and announced it secured $64 million across its seed round and Series A.
>> Click here for more f... |
| 29.06.2026 | Lycia Therapeutics Raises $75M in Series D Funding | Lycia Therapeutics, a South San Francisco, California-based developer of extracellular protein degradation and lysosomal targeting chimera (LYTAC) therapeutics, raised $75m in Series D funding.
The round was co-led by Janus Henderson Invest... |
| 29.06.2026 | Lycia Therapeutics Raises $75 Million Series D To Advance LYTAC Pipeline | Lycia Therapeutics announced that it has completed an oversubscribed $75 million Series D financing. The financing was co-led by existing investor Janus Henderson Investors and new investor Balyasny Asset Management. The round also included... |
| 25.06.2026 | Arca Raises $64 Million To Build AI-Native Wealth Management Platform | Arca announced its emergence from stealth, having raised $64 million across its seed round and Series A.
The company is an AI-native wealth management platform that combines personalized, advisor-led financial services with purpose-built AI... |
| 11.05.2026 | CellCentric Secures $220M to Accelerate Myeloma Drug Inobrodib | CellCentric secured $220 million in Series D funding. This capital fuels pivotal clinical trials for inobrodib. Inobrodib is a novel oral p300/CBP inhibitor. It targets relapsed or refractory multiple myeloma. Phase 2 data demonstrated sign... |
| 07.05.2026 | CellCentric: $220 Million Series D Raised To Advance Inobrodib Trials For Multiple Myeloma | CellCentric announced the completion of an oversubscribed $220 million Series D financing to support pivotal clinical trials of inobrodib, the company’s first-in-class oral p300/CBP inhibitor for the treatment of multiple myeloma.
The finan... |
| 06.05.2026 | CellCentric Announces Oversubscribed $220 Million Series D Financing to Advance Pivotal Trials of Inobrodib in Multiple Myeloma | CellCentric, a clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma, today announced the completion of an oversubscribed $220 million Series D financing... |
| 04.05.2026 | Euclid Acquires Thresh | Euclid, a Bloomington, MN-based operating system for renewable energy M&A, project development, financing, and operations, announced the acquisition of Thresh Power, an AI-powered platform that automates diligence for renewables project... |
| 21.04.2026 | Zero Networks launches AI Segmentation to govern autonomous AI agents
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Zero-trust security startup Zero Networks Ltd. today announced the launch of AI Segmentation, a set of platform capabilities designed to give enterprises identity-based control over autonomous artificial intelligence agents and block AI-dri... |
| 15.04.2026 | Gitar Raises $9M in Funding | Gitar, a San Francisco, CA-based developer infrastructure company building AI agents for code review and continuous integration workflows, raised $9M in funding.
The round was led by Venrock with participation from Sierra Ventures.
The comp... |
| 16.03.2026 | Alto Neuroscience: $120 Million Raised To Advance Treatment-Resistant Depression Drug Candidate | Alto Neuroscience, a clinical-stage biopharmaceutical company developing precision medicines for neuropsychiatric disorders, announced it has secured approximately $120 million in a private placement financing.
The financing was led by Comm... |
| 07.03.2026 | When sci-fi becomes real life | - |
| 21.02.2026 | Korsana Biosciences Launches With $175 Million To Advance Alzheimer’s Therapeutics | Korsana Biosciences, a biotechnology company focused on discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, announced its emergence from stealth with $175 million in funding from a syndicate of hea... |
| 18.02.2026 | Korsana Biosciences Raises $175M in Funding | Korsana Biosciences, a Waltham, MA-based biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, raised $175M in total funding.
The amount consisted of a $25M Seed investment from... |
| 16.02.2026 | IBJ Podcast: Here’s how BiomEdit raised $18.4M in a tough VC year | - |
| 04.02.2026 | GenLogs: $60 Million Series B Raised For Freight Intelligence Platform | GenLogs, a freight intelligence provider deploying its Truck Intelligence technology to improve supply chain efficiency and combat cargo theft, has closed a $60 million Series B financing. The round was led by Battery Ventures with particip... |
| 04.02.2026 | GenLogs Raises $60M in Series B Funding | GenLogs, an Arlington, VA-based provider of a truck intelligence platform, raised $60M in Series B funding.
The round was led by Battery Ventures with participation by IVP, Cathay Innovation, and 9Yards, as well as existing investors Venroc... |
| 03.02.2026 | GenLogs secures $60M to keep tabs on trucking industry with AI and roadside sensors
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Trucking intelligence startup GenLogs Corp. says it’s going to inject artificial intelligence smarts into the freight industry after raising $60 million in a new round of funding today.
The Series B round was led by Battery Ventures and saw... |
| 01.02.2026 | Focus on biopharma comes at the right time: Industry | - |
| 14.01.2026 | Mirador Therapeutics Secures $250M, Accelerates Precision Medicine | Mirador Therapeutics secured $250M in Series B funding. This propels their innovative precision medicine strategy. Total capital raised now exceeds $650M. The San Diego firm targets immune-mediated inflammatory and fibrotic diseases. Funds ... |
| 13.01.2026 | Mirador Raises $250M in Series B Funding | Mirador Therapeutics, a San Diego, CA-based clinical-stage precision medicine company developing new therapies for immune-mediated inflammatory and fibrotic diseases, raised $250M in Series B funding.
Backers included T. Rowe Price Investme... |
| 12.01.2026 | Mirador Therapeutics: $250 Million Series B Raised And Multi-Asset Immuno-Fibrotic Pipeline Advanced | Mirador Therapeutics announced it is advancing multiple clinical-stage programs across Crohn’s disease, ulcerative colitis, rheumatoid arthritis, and idiopathic pulmonary fibrosis, with more than 10 clinical readouts expected by the end of ... |
| 23.12.2025 | FINNY: $17 Million Series A Raised To Expand AI Prospecting And Marketing Platform For Financial Advisors | FINNY AI, an AI-powered prospecting and marketing platform built specifically for financial advisors, has raised $17 million in Series A funding to scale product development and go-to-market efforts amid renewed industry emphasis on organic... |
| 22.12.2025 | AI Startup FINNY Raises $17M for Advisor Prospecting Push | Image: Adobe Stock
FINNY has secured $17 million in Series A funding to boost the AI platform’s plans to help financial advisors discover and convert prospects across the industry.
The investment round, spearheaded by venture capital firm V... |
| 20.12.2025 | FINNY Raises $17m Led by Venrock for AI Advisor Prospecting Platform | FINNY AI Inc, an AI prospecting and marketing platform for financial advisors, has raised $17 million in Series A funding as firms seek to automate client acquisition for registered investment advisers.
The round was led by venture firm Ven... |
| 19.12.2025 | FINNY Raises $17M in Series A Funding | FINNY, a New York City-based developer of an AI-powered prospecting and marketing platform for financial advisors, raised $17m in Series A funding.
Venrock led the round with participation from former Vanguard chairman and CEO William McNab... |
| 11.12.2025 | Walton family fortune: How America’s richest family manages their wealth | The Waltons, America’s richest family, uses a model pioneered by the Rockefellers to manage their wealth.
As the Walmart heirs have gotten richer, the Waltons have put their growing wealth in the hands of a network of family offices to make... |
| 03.11.2025 | Tubulis: Second Tranche Of €344 Million Series C Closed To Advance ADC Pipeline | Tubulis announced the second and final closing of its Series C financing round, bringing the total raised to €344 million ($401 million). The round included new investors Fidelity Management & Research Company, Janus Henderson Investors... |
| 30.10.2025 | Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $ 401M) |
MUNICH, GERMANY, October 30, 2025 – Tubulis today announced a second and final closing of its Series C round totaling €344M (US $401M). The second closing brought in additional new investors Fidelity Management & Research Company, Janu... |
| 29.10.2025 | Syllo: $30 Million Closed To Advance AI-Driven Litigation Innovation And Expansion | Syllo, a rapidly growing provider of AI-powered litigation technology, has raised $30 million in growth funding led by Venrock and Two Seas Capital, with participation from strategic individual investors. The investment will drive product i... |
| 28.10.2025 | Syllo Raises $30M in Growth Funding | Syllo, a NYC-based provider of a litigation workspace, raised $30M in growth funding.
Backers included Venrock, Two Seas Capital, and strategic individuals.
The company intends to use the funds to bolster product innovation and development ... |
| 15.10.2025 | Tubulis Raises €308 Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline | • USD 361 million round represents the largest Series C for a European biotechnology company and the largest financing for a private ADC developer globally
• Round led by Venrock Healthcare Capital Partners with participation from other new... |
| 09.10.2025 | Expedition resupplies for phase 2 COPD voyage with $165M series A | Expedition Therapeutics is gearing up for a phase 2 trek with a $165 million series A that closed Oct. 9. The new funding will fuel the Bay Area biotech’s DPP1 inhibitor EXPD-101 as it ventures into a study in patients with chronic obstruct... |
| 09.09.2025 | Euclid Power Secures $20M to Accelerate AI-Driven Renewable Energy Deployment | Euclid Power just secured $20 million in Series A funding. Venrock led the round, with HSBC Asset Management also investing. This capital fuels Euclid's AI-powered operating system for renewable energy. The platform streamlines project deve... |
| 08.09.2025 | Euclid Power: $20 Million Series A Closed For Advancing Renewable Energy Deployment | Euclid Power, an operating system for renewable energy project development, financing, and operations, announced a $20 million Series A round led by Venrock, with participation from HSBC Asset Management and existing investors including Spe... |
| 05.09.2025 | Euclid Power Raises $20M in Series A Funding | Euclid Power, a NYC-based provider of an operating system for renewable energy project development, raised $20M in Series A funding.
The round was led by Venrock, with participation from HSBC Asset Management and existing investors includin... |
| 15.07.2025 | Collate Raises $10M in Series A Funding | Collate, the Menlo Park, CA-based creator of OpenMetadata, an open source project for data intelligence, raised $10M in Series A funding.
The round was led by Venrock. Additional investors included Unusual Ventures and Karman Ventures.
The ... |
| 09.07.2025 | Moment Raises $36 Million to Automate Fixed Income for Financial Institutions | Moment was founded by the team that built the automated credit desks at Citadel Securities and Jane Street, and its partnership with LPL Financial underscores surging demand for automated fixed-income solutions
NEW YORK, July 9, 2025 /PRNew... |
| 09.07.2025 | Moment Raises $36M in Series B Funding | Moment, a NYC-based company automating trading and portfolio management workflows for fixed income teams, raised $36M in Series B funding.
The round was led by Index Ventures, with participation from Andreessen Horowitz, Lightspeed Venture ... |
| 09.06.2025 | Zero Networks: $55 Million Series C Closed To Transform Network Security | Zero Networks, the cybersecurity company reclaiming microsegmentation to deliver on its promise, announced it raised $55 million in Series C funding. The funding round was led by Highland Europe, with participation from existing investors F... |
| 04.06.2025 | Zero Networks: A Cybersecurity Phoenix Rises with $55 Million Funding | In the digital age, cybersecurity is the fortress that guards our most valuable assets. As cyber threats evolve, so must our defenses. Enter Zero Networks, an Israeli startup that has just raised $55 million in a Series C funding round. Thi... |
| 03.06.2025 | Zero Networks raises $55 million to expand microsegmentation and zero-trust solutions
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our missio... | Israeli cybersecurity startup Zero Networks Ltd. announced today that it has raised $55 million in new funding to expand its team and scale up go-to-market efforts worldwide.
Founded in 2019, Zero Networks offers automated, agentless micros... |
| 03.06.2025 | Zero Networks Raises $55M in Series C Funding | Zero Networks, an Orlando, FL-based cybersecurity company, raised $55M in Series C funding.
The round, which brought total funding to more than $100M, was led by Highland Europe, with participation from existing investors F2 Venture Capital... |
| 20.05.2025 | Adyton Secures $11 Million to Revolutionize Military Operations | In a world where speed and precision can mean the difference between victory and defeat, Adyton has emerged as a game-changer. The Dallas-based company recently secured $11 million in funding, a lifeline that promises to reshape how the U.S... |
| 18.05.2025 | Adyton: $11 Million Secured For Digitizing And Automating Operational Processes | Adyton announced $11 million in funding, led by Venrock with participation from Khosla Ventures, Liquid 2 Ventures, Alumni Ventures, Initialized Capital, Kindred Ventures, and Leblon Capital. The company also revealed a multi-year deal wort... |
| 15.05.2025 | Adyton Raises $11M in Funding | Adyton, a Dallas, TX-based provider of an operations kit digitizing and automating Department of Defense operations, raised $11M in funding.
The round was led by Venrock with participation from Khosla Ventures, Liquid 2 Ventures, Alumni Ven... |
| 02.05.2025 | Astronomer’s $93 Million Bet on Data Pipelines: A New Era for DataOps | In the fast-paced world of technology, data is the new oil. Companies are racing to refine it, to extract insights that drive decisions. Astronomer Inc. is at the forefront of this race, recently securing a hefty $93 million in Series D fun... |
| 02.05.2025 | Astronomer: $93 Million Series D Raised For DataOps Platform | Astronomer (the company behind Astro, a leading unified DataOps platform powered by Apache Airflow) announced it has secured $93 million in Series D funding led by Bain Capital Ventures, along with Salesforce Ventures and existing investors... |
| 02.05.2025 | Astronomer Secures $93 Million Series D Funding to Deliver Unified DataOps Platform for Enterprise AI | Financing led by Bain Capital Ventures, alongside Salesforce Ventures and all existing investors, with Bosch Ventures seeking to participate, will drive global expansion and accelerate R&D
Astronomer, the company behind Astro, the leadi... |
| 01.05.2025 | Astronomer Raises $93M in Series D Funding | Astronomer, a NYC-based provider of a unified DataOps platform powered by Apache Airflow®, raised $93m in Series D funding.
The round was led by Bain Capital Ventures, with participation from Salesforce Ventures and existing investors inclu... |
| 01.05.2025 | Astronomer’s $93M raise underscores a new reality: Orchestration is king in AI infrastructure | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
Astronomer, the company behind the Apache Airflow-powered data orchestration platform Astro, has secured $93 mill... |
| 03.04.2025 | Suki Launches AI Prescription Order Generation from Ambient Visits | What You Should Know:
– Suki, the leader in artificial intelligence (AI) technology for healthcare, today announced the industry’s first-ever capability to generate and stage prescription orders from ambient visits.
– This new feature will ... |
| 20.03.2025 | With $6.2B Purchase Of Chip Designer Ampere, SoftBank Is Going Big This Year | 0 Shares Email Facebook Twitter LinkedIn
As an investor, SoftBank is known for going big.
That mentality came across clearly Wednesday evening, when the storied tech dealmaker announced it will acquire chip design company Ampere Computing, ... |
| 28.02.2025 | The Rise of Auditoria.AI: Transforming Corporate Finance with Agentic AI | In the bustling tech landscape of Silicon Valley, innovation is the lifeblood of progress. Among the myriad of startups, Auditoria.AI stands out like a lighthouse in a storm. This San Jose-based company has just secured $38 million in Serie... |
| 25.02.2025 | Auditoria.AI raises $38 million | Auditoria.AI Auditoria.AI
Founded: 2019
Headquarters: San Jose, California, United States
Total Funding: $59.5M
See full company profile "> , an AI-powered finance automation platform, has raised $38 million in Series B funding led ... |
| 25.02.2025 | Auditoria.AI Raises $38M in Series B Funding | Auditoria.AI, a San Jose, CA-based company which specializes in agentic AI for the Office of the Chief Financial Officer (CFO), raised $38M in Series B funding.
The round was led by Innovius Capital with participation from Dell Technologies... |
| 06.02.2025 | GenLogs Secures $14.6M to Revolutionize Freight Intelligence | In the fast-paced world of logistics, data is the new gold. GenLogs, a freight intelligence platform based in Arlington, Virginia, has struck a rich vein with its recent $14.6 million Series A funding round. This infusion of capital, led by... |
| 05.02.2025 | GenLogs Raises $14.6M in Series A Funding | GenLogs, an Arlington, VA-based provider of a freight Intelligence platform raised $14.6M in Series A funding.
The round was led by Venrock and HOF Capital, with participation from Steel Atlas, AutoTech Ventures, Venture53, TitletownTech, P... |
| 03.02.2025 | GenLogs Raises $14.6M Series A Led by Venrock, HOF Capital to Drive Freight Efficiency and Security | GenLogs' Intermodal Insights
GenLogs' Asset Locator Tool
GenLogs Founding Team (L-R): Joe Sherman (CTO), Ryan Joyce (CEO), Blake Balch (CSO)
The GenLogs Freight Intelligence platform is quickly becoming one of the most indispensable tools o... |
| 23.01.2025 | The Dance of Deals: China’s Biopharmaceuticals and India’s Renewable Energy | In the world of business, deals are like dances. They require rhythm, timing, and the right partners. Recently, two significant transactions emerged from Asia, showcasing the dynamic interplay between innovation and investment. One involves... |
| 21.01.2025 | China's KeyMed, InnoCare Grant Prolium Bio Global Rights to Cancer Drug for USD520 Million | (Yicai) Jan. 21 -- KeyMed Biosciences and InnoCare Pharma have granted RTW Investments-backed Prolium Bioscience exclusive global rights to a novel antibody-drug conjugate still in clinical trials, with the deal potentially worth more than ... |
| 16.01.2025 | Timberlyne Therapeutics: $180 Million (Series A) Raised For Advancing CM313 | Timberlyne Therapeutics – a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders – announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in... |
| 13.01.2025 | Timberlyne: $180 Million (Series A) Raised To Develop Novel Therapies For Autoimmune Disorders | Timberlyne Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders, announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in-c... |
| 22.11.2024 | Metsera: $215 Million (Series B) Raised To Develop Medicines For Obesity And Metabolic Diseases | Metsera – a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases – announced the closing of a $215 million Series B funding round to further advance its portfolio of highl... |
| 14.11.2024 | Metsera Raises $215M in Series B Financing | Metsera, a NYC-based clinical-stage biopharmaceutical company, raised $215M in Series B funding.
The round was led by Wellington Management and Venrock, with participation from Fidelity Management and Research Company, Janus Henderson Inves... |
| 30.10.2024 | GlycoMimetics To Acquire Crescent Biopharma | GlycoMimetics (NASDAQ: GLYC), a Rockville, MD-based late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, acquired Crescent Biopharma, Inc., a biotechnology company advancing a pipeli... |
| 25.10.2024 | Interos: $40 Million Raised From Blue Owl Capital | Interos, a leader in AI-based supply chain risk intelligence trusted by over 100 Fortune 1000 companies and numerous leading federal agencies, announced a strategic $40 million growth capital investment from funds managed by Blue Owl Capita... |
| 24.10.2024 | Jade Biosciences Extends Financing; Total To $95M | Jade Biosciences, a Vancouver, BC, Canada-based biotechnology company dedicated to developing therapies for patients living with autoimmune diseases, extended its financing, bringing the total raised to $95M.
The round added Frazier Life Sc... |
| 15.10.2024 | Suki: AI-Based Healthcare Leader Raises $70 Million (Series D) | Suki, a leader in artificial intelligence (AI) technology for healthcare, announced $70 million in new funding on the strength of its health system and electronic health record (EHR) partnerships, including collaborations with Epic, Oracle ... |
| 14.10.2024 | Scope3: Collaborative Sustainability Platform Company Raises $25 Million | Scope3, a collaborative sustainability platform decarbonizing media and advertising, announced the closing of $25 million in a strategic funding round led by GV. The funding round included participation from existing investors Venrock, Room... |
| 11.10.2024 | Scope3 Raises $25M in Funding to Expand into Sustainable AI | Scope3, the collaborative sustainability platform decarbonizing media and advertising, announced the closing of $25 million in new funding led by GV. The round included participation from existing investors Venrock, Room40 Ventures, and Cra... |
| 10.10.2024 | Suki's $70 Million Leap: Revolutionizing Healthcare with AI | In the fast-paced world of healthcare, Suki is making waves. The company recently secured $70 million in funding, pushing its total to $165 million. This investment, led by Hedosophia and backed by Venrock and other existing investors, aims... |
| 10.10.2024 | Suki Secures $70 Million Series D Funding as Demand Surges, Expands Strategic Partnership with MedStar Health | Unprecedented growth, including 12+ new health system partnerships and expansion with MedStar Health, drives latest investment
Related Posts
The Role of AI in Protecting Consumers and Businesses From Modern Fraud
Oct 11, 2024
AMD Launches 5... |
| 10.10.2024 | Suki raises $70M for its healthcare-focused AI assistant
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provide free, deep, and ... | Suki AI Inc., a startup with an artificial intelligence assistant for healthcare professionals, has raised $70 million in funding to enhance its technology.
London-based fund Hedosophia led the Series D investment. Suki said in its announce... |
| 10.10.2024 | Suki secures $70M to enhance its AI ambient scribe offerings | Photo: Hero Images Inc./Getty Images
Suki, maker of an AI-backed healthcare voice tool, announced it raised $70 million in Series D funding, bringing its total raise to $165 million.
Hedosophia led the round, with additional investment from... |
| 10.10.2024 | Suki Raises $70M to Advance AI-Powered Solutions for Healthcare | What You Should Know:
– Suki, a provider of artificial intelligence (AI) technology for healthcare raises $70M in new funding, bringing its total funding to $165M.
– The investment, led by Hedosophia with significant participation from Venr... |
| 10.10.2024 | Scope3 Raises $25 Million in Funding to Expand into Sustainable AI | Scope3, the collaborative sustainability platform decarbonizing media and advertising, today announced the closing of $25 million in new funding led by GV. The round included participation from existing investors Venrock, Room40 Ventures, a... |
| 01.10.2024 | The 10 Biggest Rounds Of September: Safe Superintelligence’s $1B Raise Reigns Supreme | 1 Shares Email Facebook Twitter LinkedIn
This is a monthly feature that runs down the month’s top 10 funding rounds in the U.S. Check out the biggest rounds of last month here.
Lots of big rounds as summer fades into fall. AI startup Safe S... |
| 20.08.2024 | Vanilla: Estate Planning Software Company Raises Strategic Funding | Estate planning software company Vanilla announced a strategic funding round led by returning investor Insight Partners, with participation from Venrock, Vanguard, and other previous investors. Vanilla also welcomes new strategic investor E... |
| 25.07.2024 | Element Biosciences: A New Era in DNA Sequencing**
** | ** Element Biosciences is on a mission. The San Diego-based company is reshaping the landscape of DNA sequencing and multi-omics technology. With a recent infusion of over $277 million in Series D funding, Element is poised to democratize a... |
| 23.07.2024 | Element Biosciences: Over $277 Million In Series D Raised For Democratizing Access To Advanced Biological Tools | Element Biosciences, a developer of pioneering technologies to empower science, announced over $277 million in Series D funding to support its growing global customer base with disruptive DNA sequencing and multi-omics technologies for year... |
| 26.06.2024 | CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He | BEIJING, June 26, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI) ("CASI" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and ... |
| 17.06.2024 | Bright Peak Therapeutics raises USD90 million to advance lead program into clinical trials |
Bright Peak Therapeutics is a biotechnology company advancing a portfolio of multifunctional immunotherapies to treat cancer and other diseases. “We are now well positioned to bring much needed innovation to the field of anti-PD-1 immune-c... |
| 08.01.2024 | Exclusive: Venrock ups its find size for the first time in a decade, raising $650M for tenth fund | It was mid-December as Venrock partner Bryan Roberts waltzed into one of the conference rooms of the venture capital firm he’s been running since 2007—his German Shepherd close at his heels with a tennis ball.
When I asked how he’s been, he... |
| 26.06.2023 | Pharvaris obtains $70 million in a private placement round | |
| 21.06.2023 | Aledade Raises $260M to Expand Services for Network of Primary Care Practices | What You Should Know:
Aledade, a Bethesda, MD-based network of independent primary care practices raises $260M in a Series F funding round led by new investor Lightspeed Venture Partners, with participation from Venrock, Avidity Partners, O... |
| 14.09.2022 | YC’s 1st Health and Bio Summit | We’re excited to announce the first YC Health and Bio Summit that will take place in San Francisco on October 21, 2022.
The half day conference will feature bio and healthcare founders and investors who will tell their stories and share ad... |
| 01.06.2022 | This is the beginning of the unbundled database era | Ethan Batraski Contributor
Share on Twitter
Ethan Batraski is a partner at Venrock and focuses on data infrastructure, open source and developer tools.
More posts by this contributor
Eight trends accelerating the age of commercial-ready qua... |
| 22.02.2022 | Zero Networks Raises $20M Led by Venrock to Expand Pioneering, Effortless Segmentation to Stop the Spread of Ransomware | “Solutions today fail to protect enterprises from lateral movement and ransomware because they're expensive and cumbersome to deploy. Zero Networks’ MFA-based approach simplifies one of the hardest problems in cyber security regardless of c... |
| 04.01.2022 | Silicon Valley Investors Haven’t Let the Theranos Scandal Change the Way They Do Business | Many Silicon Valley venture capitalists continued to invest on promising new health technology start-ups as Theranos founder Elizabeth Holmes stood trial on charges of defrauding investors and patients. Even in the wake of the infamous scan... |
| 07.12.2021 | Suki Secures $55M for Voice-Enabled Clinical Assistants to Relieve Physician Burnout | What You Should Know:
– Suki raises $55M in Series C funding to expand its AI-enabled, voice-enabled clinical assistants to relieve physician burnout.
– Suki will use this funding to make strategic investments that will lead to an expansion... |
| 30.08.2021 | Vanilla Raises $11.6 Million With Venrock, Announces High-Profile Partners, Welcomes Former Vanguard Group Chairman McNabb to Board | Vanilla’s breakthrough service integrates the financial and legal sides of estate planning and automates complex estate planning logic. It creates a valuable new revenue stream for advisors and greatly increases their retention and prospect... |
| 19.08.2021 | Let’s make a deal: A crash course on corporate development | Todd Graham Contributor
Share on Twitter
Todd Graham is vice president at Venrock, a pioneering venture capital firm established in 1969.
Wash, rinse, repeat: A startup is founded, first product ships, customers engage, and then a larger co... |
